Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A. Kharfan‐Dabaja, Marcie Riches, A. Samer Al‐Homsi et al.|Transplantation and Cellular Therapy|2021Cited by 180
Comparative Analysis of Calcineurin Inhibitor–Based Methotrexate and Mycophenolate Mofetil–Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Betty K. Hamilton, Ying Liu et al.|Biology of Blood and Marrow Transplantation|2018Cited by 51
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancerMelissa Khaw, Jeffrey S. Miller, Nicholas A. Zorko et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 8
Abstract 1241: Enhancing NK cell therapy for head and neck cancer within the solid tumor microenvironment using a B7H3-targeting tri-specific killer engager (TriKE)Melissa Khaw, Jeffrey S. Miller, Nicholas A. Zorko et al.|Cancer Research|2024Cited by 0